A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies
暂无分享,去创建一个
D. Ouellet | J. Snoeys | J. Jiao | J. de Jong | J. Sukbuntherng | P. Hellemans | C. Panizo | T. Masterson | G. Manikhas | A. Myasnikov | V. Chauhan | D. Osmanov | D. Patricia | R. Córdoba | L. de Zwart | Severijn De Wilde